Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 375

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 375
---
 by the reporting date and are expected to apply
when the deferred tax assets or liabilities are recovered or settled.

Property, plant and equipment

Property, plant and
equipment is stated at cost, net of accumulated depreciation and accumulated impairment losses.

Depreciation is provided
on all items of property, plant and equipment so as to write off their carrying value over their expected useful economic lives. It is
provided at the following rates:

| Schedule of depreciation rates of property, plant and equipment |                                                                     |
| Fixtures and fittings                                           | – 20%- 25% per annum straight line                                  |
| Leasehold improvements                                          | – the shorter of 10% per annum straight line or over the lease term |
| Computer equipment                                              | – 25% per annum straight line                                       |
| Laboratory equipment                                            | – 15% – 25% per annum straight line                                 |
| Right of use asset                                              | – Economic life of contractual relationship                         |

| F-38 |

| 2 | Critical accounting estimates and judgements |

The preparation of these
consolidated financial statements requires the Group to make estimates, assumptions and judgments that can have a significant impact on
the reported amounts of assets and liabilities, revenue and expenses and related disclosure of contingent assets and liabilities, at the
respective dates of our financial statements. The Group bases its estimates, assumptions and judgments on historical experience and various
other factors that we believe to be reasonable under the circumstances. Actual results may differ from these estimates under different
assumptions or conditions. Management evaluates estimates, assumptions and judgments on a regular basis and makes changes accordingly
and discusses critical accounting estimates with the board of Directors.

The following are considered
to be critical accounting estimates:

Impairment of intangible
assets not yet ready for use

Intangible assets not
yet ready for use are tested for impairment at the cash generating unit level on an annual basis at the year end and between annual tests
if an event occurs or circumstances change that would more likely than not reduce the fair value of a cash generating unit below its carrying
value. Impairment indications include events causing significant changes in any of the underlying assumptions used in valuing intangibles
not ready for use. The key assumptions are the probability of success, the discount factor, the timing of future revenue flows, market
penetration and peak sales assumptions, and expenditure required to complete development.

The fair value of each
cash generating unit or asset is estimated using the income approach, on a discounted cash flow methodology.